Expertise in
1
conditions

Ilias Athanasiadis

Athens, ESYE31, GR 
Expertise in
1
conditions
Athens, ESYE31, GR 

Overview

Ilias Athanasiadis practices practicing medicine in Athens, Greece.

Mr. Athanasiadis is highly rated in 1 condition, according to our data. His clinical expertise encompasses Osteonecrosis, Ascites, Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy.

He is actively involved in clinical research, co-authoring 33 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Athens, ESYE31, Greece
Other Locations
Marousi, ESYE31 15123, Greece
Thessaloniki, ESYE12, Greece
Kilkis, ESYE12, Greece

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Clinical and Molecular Study With Digital Support of Patients With Inoperable Lung Cancer
Clinical and Molecular Study With Digital Support of Patients With Inoperable Lung Cancer
Enrollment Status: Completed
Publish Date: June 24, 2026
Intervention Type: Other
A Open Label, Non Randomized, Phase Two Trial in Metastatic Colorectal Cancer (mCRC) With the Combination of m FOLFIRI Plus Aflibercept as First Line Treatment: MINOAS Trial
A Open Label, Non Randomized, Phase Two Trial in Metastatic Colorectal Cancer (mCRC) With the Combination of m FOLFIRI Plus Aflibercept as First Line Treatment: MINOAS Trial
Enrollment Status: Unknown
Publish Date: February 22, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Longitudinal Study Evaluating Molecular Changes Associated With Resistance to First and Third (AZD9291) Generation EGFR TKIs in Patients With EGFR Mutant NSCLC Using Liquid Biopsy
A Longitudinal Study Evaluating Molecular Changes Associated With Resistance to First and Third (AZD9291) Generation EGFR TKIs in Patients With EGFR Mutant NSCLC Using Liquid Biopsy
Enrollment Status: Unknown
Publish Date: February 22, 2019
Intervention Type: Drug
Study Drug: AZD9291
Study Phase: Phase 2
View 2 Less Clinical Trials

33 Total Publications

Comprehensive molecular profiling of advanced NSCLC in Greek patients:A prospective HeCOG study.
Comprehensive molecular profiling of advanced NSCLC in Greek patients:A prospective HeCOG study.
Journal: Cancer treatment and research communications
Published: March 17, 2026

Frequently Asked Questions about Ilias Athanasiadis

Is Ilias Athanasiadis a top-rated expert for Osteonecrosis?

MediFind is an objective health platform that identifies experts based on real-world data. Ilias Athanasiadis is classified as an Advanced expert for Osteonecrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ilias Athanasiadis participate in research or clinical trials?

Yes. Ilias Athanasiadis has published 33 articles and abstracts on conditions like Osteonecrosis. You can view a list of Ilias Athanasiadis's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Athanasiadis's expertise for a condition
ConditionClose
      View All 17 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile